Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Volume:9 Issue:11 Number:34 ISSN#:2563-5476
RCT
ACE Report #12645
Ace Report Cover General Orthopaedics

Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk


How to Cite

OrthoEvidence. Polypill/Aspirin Combination Reduces Cardiovascular Events in Participants with Increased CV Risk. ACE Report. 2020;9(11):34. Available from: https://myorthoevidene.com/AceReport/Report/12645

Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Polypill with or without Aspirin in Persons without Cardiovascular Disease

N Engl J Med. 2020 Nov 13.

Contributing Authors: S Yusuf P Joseph A Dans K Teo D Xavier P Lopez-Jaramillo K Yusoff A Santoso H Gamra S Talukder C Christou P Girish K Yeates F Xavier G Dagenais C Rocha T McCready J Tyrwhitt J Bosch P Pais TIPS-3 Investigators

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Five thousand, seven hundred and thirteen patients with elevated cardiovascular risk were randomized to receive a polypill (containing lipid and blood pressuring lowering agents), aspirin, polypill and aspirin, or placebo for the prevention of cardiovascular events. The primary outcome of interest for the polypill and polypill plus aspirin groups was a composite of death from major cardiovascular ...

To view the full report, start your 30-day free trial today

No credit card required

JOIN Forgot Password?

Not sure if you want to join OrthoEvidence?

Access this report without an Account.

Success, an email containing a link to access this report has been sent to your inbox.

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.

LEARN MORE

Please Login or Join to leave comments.